The $150,000 Michelson Prizes are awarded annually to support early-career investigators working to advance human immunology, vaccine discovery, and immunotherapy research for major global diseases.
As in other years, we will be looking for research aimed at tackling the current roadblocks that exist in human vaccine development and expanding our limited understanding of key immune processes that are fundamental to successful vaccine and immunotherapy development.
Deadline for submission is June 9, 2024.
A rigorous and competitive international search will identify the most innovative projects from young scientists working across a broad range of scientific fields. Proposals will be reviewed by a distinguished committee of internationally-recognized scientists. The review committee will be looking for research that challenges dogma, from researchers who clearly articulate a vision that demonstrates an ability to look beyond convention to make a lasting impact on vaccine and immunotherapy research. We encourage applications from the full spectrum of scientific disciplines related to immunology, vaccine, and immunotherapy research, including but not limited to:
- Clinical Research
- Molecular Biology
- Computer science
- Biophysics
- Bioengineering
- Environmental Health
- Biochemistry
- Protein Engineering
- AI/Machine Learning
- Nanotechnology
- Microbiome
- Vector Biology
Applicants must be 35 or younger at the time of submission. Early career independent investigators, postdoctoral fellows, clinical fellows (including residents and interns), and other researchers currently in training positions are eligible for these awards. Applicants must be employed by, or affiliated with, an eligible organization (e.g., academia, biotechnology companies, foundations, government and non-governmental organizations, and research institutes).